Division of Vascular Surgery, Department of Surgery, The Johns Hopkins Hospital, Baltimore, MD.
Division of Vascular Surgery, Department of Surgery, The Johns Hopkins Hospital, Baltimore, MD.
J Vasc Surg. 2014 Jun;59(6):1651-6. doi: 10.1016/j.jvs.2013.12.042. Epub 2014 Feb 4.
Central vein stenosis or occlusion remains an unfortunate complication associated with the use of dialysis catheters. In patients with a functioning arteriovenous fistula, central vein stenosis can lead to debilitating arm, breast, or neck swelling. Treatment typically involves central vein angioplasty or stenting, or both, but restenosis and reocclusion rates remain high. Presented here are the initial results of a unique series of patients with a mature arteriovenous access and symptomatic upper extremity venous hypertension who were treated with axillary vein-to-femoral vein bypass after endovascular therapy failed.
This was a retrospective analysis of 10 hemodialysis patients with a functioning right upper extremity access who underwent axillary vein-to-femoral vein bypass between December 2011 and April 2013.
The 10 patients (seven men) were a median age of 58 years. All patients had documentation of prior central venous catheter placement and had undergone a previous endovascular procedure that was unsuccessful or technically unfeasible. The median hospital stay was 2 days (range, 1-3 days), and the median assisted-primary patency was 197 days (25th-75th percentile, 114-240 days). Three patients presented with recurrent arm swelling that was successfully managed in one patient with revision of the proximal anastomosis. Three additional patients presented with subsequent lower extremity swelling, with one patient benefitting from femoral vein angioplasty. Ultimately, six patients continued to use their original access, and two required placement of interval central venous catheters for hemodialysis.
In patients who have exhausted all endovascular options, axillary-to-femoral vein bypass may represent a safe and efficacious approach to alleviate extremity swelling while simultaneously salvaging a functional dialysis access.
中心静脉狭窄或闭塞仍然是与透析导管使用相关的不幸并发症。在有功能的动静脉瘘患者中,中心静脉狭窄可导致手臂、乳房或颈部严重肿胀。治疗通常包括中心静脉血管成形术或支架置入术,或两者兼施,但再狭窄和再闭塞率仍然很高。本文介绍了一组独特的患者的初步结果,这些患者有成熟的动静脉通路和症状性上肢静脉高压,在血管内治疗失败后,采用腋静脉至股静脉旁路转流治疗。
这是一项回顾性分析,纳入了 2011 年 12 月至 2013 年 4 月期间 10 例接受腋静脉至股静脉旁路转流的功能正常的右上臂通路血液透析患者。
10 例患者(7 例男性)的中位年龄为 58 岁。所有患者均有中心静脉导管放置的记录,并接受过先前的血管内手术,但不成功或技术上不可行。中位住院时间为 2 天(范围,1-3 天),中位辅助性一期通畅率为 197 天(25 百分位至 75 百分位,114-240 天)。3 例患者出现复发性手臂肿胀,1 例患者近端吻合口再修复后成功治疗。另外 3 例患者随后出现下肢肿胀,其中 1 例患者接受了股静脉血管成形术。最终,6 例患者继续使用其原始通路,2 例患者因血液透析需要放置间隔中心静脉导管。
对于已经用尽所有血管内治疗选择的患者,腋静脉至股静脉旁路可能是一种安全有效的方法,可以缓解肢体肿胀,同时保留功能正常的透析通路。